CardioGene Therapeutics

CardioGene is focused on the development of novel gene therapy products for the treatment of cardiovascular disease
(Formerly Genocor, Inc.)

(1997)

Management:
Martin Cleary, President & CEO

UM Inventor(s):
Jeffrey M. Leiden, Betsy Nabel, Gary Nabel

Acquisitions:
Boston Scientific [NYS:BSX] in 1998